Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)Kamran Ghoreschi, John J. O’Shea|The Journal of Immunology|2011Cited by 634
Variant <i>STAT4</i> and Response to Ruxolitinib in an Autoinflammatory SyndromeHratch Baghdassarian, Lori Broderick, Sarah A. Blackstone et al.|New England Journal of Medicine|2023Cited by 78
STAM2, a new member of the STAM family, binding to the Janus kinasesKazuhiro Endo, Kazuo Sugamura, Toshikazu Takeshita et al.|FEBS Letters|2000Cited by 76
3D chromatin architecture, BRD4, and Mediator have distinct roles in regulating genome-wide transcriptional bursting and gene networkPaweł Trzaskoma, John J. O’Shea|Science Advances|2024Cited by 16
Paxbp1 restrains cytotoxic and innate cell programs in CD4+ T cells to promote Th2 differentiationDanielle A. Chisolm, John J. O’Shea|Research Square|2025Cited by 0